» Articles » PMID: 18467911

Bile Acid Levels Are Increased in the Liver of Patients with Steatohepatitis

Overview
Specialty Gastroenterology
Date 2008 May 10
PMID 18467911
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: The pathogenesis of steatohepatitis remains largely unknown; however, bile acids may play a role as potential mediators of liver damage. The aim of this study was to characterize bile acid profiles in liver tissue of patients with steatohepatitis.

Methods: Bile acid composition was determined by gas-liquid chromatography in liver tissue from patients with nonalcoholic steatohepatitis (NASH; n=15), patients with alcoholic steatohepatitis (ASH; n=14), and controls (n=8). Liver biopsies were graded for steatosis, inflammation, and fibrosis.

Results: Bile acids were moderately increased in liver tissue of steatohepatitis patients compared with controls (P<0.05). Deoxycholic, chenodeoxycholic, and cholic acids were elevated by 92, 64, and 43%, respectively, in patients with steatohepatitis (P<0.05). Cholic acid was the prevailing bile acid in NASH patients and in controls. More hydrophobic bile acid species were elevated in ASH patients compared with controls (P<0.05). Significant correlations were found in NASH patients between hepatic chenodeoxycholic acid and fibrosis, and between cholic acid and trihydroxy/dihydroxy bile acids and inflammation (P<0.05). In patients with ASH, cholic acid and trihydroxy/dihydroxy bile acids were correlated with steatosis (P<0.01).

Conclusion: This study shows a distinct pattern of bile acids in the liver of patients with steatohepatitis. Further, the association between bile acids and histological liver injury suggests an association of specific bile acids and disease progression, possibly through bile acid-induced liver injury.

Citing Articles

Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.

Biagioli M, Fiorucci S Liver Res. 2025; 5(3):119-141.

PMID: 39957845 PMC: 11791866. DOI: 10.1016/j.livres.2021.08.003.


Maternal Western Diet Programmes Bile Acid Dysregulation and Hepatic Fibrosis in Fetal and Juvenile Macaques.

Nash M, Dobrinskikh E, Al-Juboori S, Janssen R, Fernandes J, Argabright A Liver Int. 2025; 45(2):e16236.

PMID: 39865409 PMC: 11771692. DOI: 10.1111/liv.16236.


Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD.

Termite F, Archilei S, DAmbrosio F, Petrucci L, Viceconti N, Iaccarino R Antioxidants (Basel). 2025; 14(1).

PMID: 39857390 PMC: 11759774. DOI: 10.3390/antiox14010056.


High-fat/high-sucrose diet results in a high rate of MASH with HCC in a mouse model of human-like bile acid composition.

Ueda H, Honda A, Miyazaki T, Morishita Y, Hirayama T, Iwamoto J Hepatol Commun. 2024; 9(1).

PMID: 39670881 PMC: 11637755. DOI: 10.1097/HC9.0000000000000606.


Metabolomics at the cutting edge of risk prediction of MASLD.

Tan E, Muthiah M, Sanyal A Cell Rep Med. 2024; 5(12):101853.

PMID: 39657668 PMC: 11722125. DOI: 10.1016/j.xcrm.2024.101853.